ILF2 anticorps (Internal Region)

N° du produit ABIN190786

Détail du produit anti-ILF2 anticorps

Antigène: ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))

Épitope: Internal Region

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp ILF2 est non-conjugé

Application: Western Blotting (WB), ELISA

Fonction: ILF2 / NF45

Séquence: EKAYEKPPEK KEG

Specificité: This antibody is expected to recognize both reported isoforms (NP_004506.2, NP_001254738.1).

Réactivité croisée: Chien, Humain, Souris, Rat

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Classe de qualité: Verified

Immunogène: Peptide with sequence C-EKAYEKPPEKKEG, from the internal region (near the C Terminus) of the protein sequence according to NP_004506.2.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Approx 43 kDa band observed in Human Tonsil and Thymus lysates (calculated MW of 43.1 kDa according to NP_004506.2). Recommended concentration: 0.03-0.1 μg/mL. This antibody has been successfully used in WB in the following papers: Ye J et al

Peptide ELISA: antibody detection limit dilution 1:4000.

Commentaires:

Immunoprecipitation: This antibody was confirmed by a customer in a special IP procedure called PAR-CLIP (see for method PMID: 20644507). This data is from a previous batch, not on sale.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Références pour anticorps anti-ILF2 (ABIN190786)

Shamanna, Hoque, Peery, Mathews: "Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells." dans: Oncogene, Vol. 32, Issue 43, pp. 5176-85, (2013) (PubMed).

Shamanna, Hoque, Lewis-Antes, Azzam, Lagunoff, Peery, Mathews: "The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining." dans: Molecular and cellular biology, Vol. 31, Issue 23, pp. 4832-43, (2011) (PubMed).

Détails sur ILF2

Antigène: ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))

Autre désignation: ILF2 (ILF2 Produits)

Synonymes: anticorps nf45, anticorps pro3063, anticorps ILF2, anticorps wu:fb34h01, anticorps zgc:73084, anticorps zgc:77276, anticorps NF45, anticorps PRO3063, anticorps 6230405A16Rik, anticorps TEG-267, anticorps Tex261, anticorps Tex267, anticorps interleukin enhancer binding factor 2, anticorps interleukin enhancer binding factor 2 L homeolog, anticorps ilf2, anticorps ILF2, anticorps ilf2.L, anticorps Ilf2

Sujet: ILF2, NF45, interleukin enhancer binding factor 2, 45 kDa , MGC8391, PRO3063 , interleukin enhancer binding factor 2, nuclear factor of activated T-cells, 45- kDa

ID gène: 3608, 67781, 310612

NCBI Accession: NP_004506, NP_001254738